Keywords
Graves’ Disease
Hyperthyroidism
QTc
Tpeak-Tend Interval
How to Cite
Abstract
Introduction.Graves’ disease is the most common cause of hyperthyroidism. The mortality rate increases by 20% in hyperthyroid patients; cardiac problems are the leading cause of death and arrhythmia is the most common cardiac complication.
Our study aimed to evaluate the corrected QT interval (QTc), the Tpeak-Tend interval (Tp-e), and the Tp-e/QTc ratio to predict arrhythmia risk in patients with Graves’ disease.
Methods. The study included 64 patients with Graves’ disease and 57 euthyroid controls. The 12-lead electrocardiograms of the individuals under study were evaluated. The QTc interval, the Tp-e interval, and the Tp-e/QTc ratio of all participants were determined and statistically evaluated with thyroid stimulating hormone (TSH), free triiodothyronine (fT3) and free thyroxine (fT4) values.
Results. Tp-e (p < 0.001) and QTc (p < 0.05) were significantly prolonged in the group of patients with Graves’ disease as compared to the control group. Heart rate was higher in patients with Graves’ disease as well (p < 0.05). Correlation analysis in patients with hyperthyroidism demonstrated that Tp-e (r=0.372, p=0.002), QTc (r=0.291, p=0.020), and fT3 levels were significantly and positively correlated. Similarly, Tp-e (r=0.271, p=0.030), QTc (r=0.259, p=0.039), and fT4 levels were significantly and positively correlated.
Conclusions. We observed a significant prolongation of the Tp-e and QTc intervals with the increase in fT3 and fT4 levels. On the other hand, our study demonstrated that the sensitivity and specificity of Tp-e in the prediction of hyperthyroidism were 70.3% and 70.1%, respectively (AUC=0.724 (CI: 0.629-0.818)), the optimal cut-off value=83.5 ms). The Tp-e interval, which has recently been used as one of the arrhythmogenicity indices, may be an indicator of arrhythmia risk in patients with Graves’ disease.
References
Burch HB, Cooper DS. Management of Graves Disease. JAMA. 2015;314(23):2544–2554. Available from: https://doi.org/10.1001/jama.2015.16535
Smith TJ, Hegedüs L. Graves’ disease. New England Journal of Medicine. 2016;375(16):1552–1565. Available from: https://doi.org/10.1056/NEJMra1510030
Brix TH, Kyvik KO, Christensen K, Hegedüs L. Evidence for a major role of heredity in Graves’ disease: a population-based study of two Danish twin cohorts1. The Journal of Clinical Endocrinology & Metabolism. 2001;86(2):930–934. Available from: https://doi.org/10.1210/jcem.86.2.7242
Brand OJ, Gough SCL. Genetics of thyroid autoimmunity and the role of the TSHR. Molecular and Cellular Endocrinology. 2010;322(1–2):135–143. Available from: https://doi.org/10.1016/j.mce.2010.01.013
Morshed SA, Latif R, Davies TF. Delineating the autoimmune mechanisms in Graves’ disease. Immunologic Research. 2012;54(1–3):191–203. Available from: https://doi.org/10.1007/s12026-012-8312-8
Vaidya B, Pearce SHS. Diagnosis and management of thyrotoxicosis. BMJ. 2014;349:g5128–g5128. Available from: https://doi.org/10.1136/bmj.g5128
Brandt F, Green A, Hegedüs L, Brix TH. A critical review and meta-analysis of the association between overt hyperthyroidism and mortality. European Journal of Endocrinology. 2011;165(4):491–497. Available from: https://doi.org/10.1530/EJE-11-0299
Ertek S, Cicero AF. Hyperthyroidism and cardiovascular complications: a narrative review on the basis of pathophysiology. Archives of Medical Science. 2013;9(5):944–952. Available from: https://doi.org/10.5114/aoms.2013.38685
Elming H. The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens. European Heart Journal. 1998;19(9):1391–400. Available from: https://doi.org/10.1053/euhj.1998.1094
Castro-Torres Y. Ventricular repolarization markers for predicting malignant arrhythmias in clinical practice. World Journal of Clinical Cases. 2015;3(8):705–720. Available from: https://doi.org/10.12998/wjcc.v3.i8.705
Yan G-X, Antzelevitch C. Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome. Circulation. 1998;98(18):1928–1936. Available from: https://doi.org/10.1161/01.CIR.98.18.1928
Yamaguchi M, Shimizu M, Ino H, Terai H, Uchiyama K, Oe K, et al. T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: a new index for arrhythmogenicity. Clinical Science. 2003;105(6):671–676. Available from: https://doi.org/10.1042/CS20030010
Dahlberg P, Diamant U, Gilljam T, Rydberg A, Bergfeldt L. QT correction using Bazett’s formula remains preferable in long QT syndrome type 1 and 2. Annals of Noninvasive Electrocardiology. 2020;26(1):e12804. Available from: https://doi.org/10.1111/anec.12804
Arteyeva NV, Goshka SL, Sedova KA, Bernikova OG, Azarov JE. What does the Tpeak-Tend interval reflect? An experimental and model study. Journal of Electrocardiology. 2013;46(4):296.e1-296.e8. Available from: https://doi.org/10.1016/j.jelectrocard.2013.02.001
Kors JA, Ritsema van Eck HJ, van Herpen G. The meaning of the Tp-Te interval and its diagnostic value. Journal of Electrocardiology. 2008;41(6):575–580. Available from: https://doi.org/10.1016/j.jelectrocard.2008.07.030
Gupta P, Patel C, Patel H, Narayanaswamy S, Malhotra B, Green JT, et al. Tp-e/QT ratio as an index of arrhythmogenesis. Journal of Electrocardiology. 2008;41(6):567–574. Available from: https://doi.org/10.1016/j.jelectrocard.2008.07.016
Bachmann TN, Skov MW, Rasmussen PV, Graff C, Pietersen A, Lind B, et al. Electrocardiographic Tpeak–Tend interval and risk of cardiovascular morbidity and mortality: Results from the Copenhagen ECG study. Heart Rhythm. 2016;13(4):915–924. Available from: https://doi.org/10.1016/j.hrthm.2015.12.027
van Noord C, van der Deure WM, Sturkenboom MCJM, Straus SMJM, Hofman A, Visser TJ, et al. High free thyroxine levels are associated with QTc prolongation in males. Journal of Endocrinology. 2008;198(1):253–260. Available from: https://doi.org/10.1677/JOE-08-0140
Lee YS, Choi JW, Bae EJ, Park WI, Lee HJ, Oh PS. The corrected QT (QTc) prolongation in hyperthyroidism and the association of thyroid hormone with the QTc interval. Korean Journal of Pediatrics. 2015;58(7):263–266. Available from: https://doi.org/10.3345/kjp.2015.58.7.263
Brent GA. Mechanisms of thyroid hormone action. Journal of Clinical Investigation. 2012;122(9):3035–3043. Available from: https://doi.org/10.1172/JCI60047
Akkuş G, Sökmen Y, Yılmaz M, Bekler Ö, Akkuş O. Comparison of 24-hour electrocardiogram parameters in patients with Graves’ disease before and after anti-thyroid therapy. Endocrine, Metabolic & Immune Disorders - Drug Targets. 2021;21(1):183–191. Available from: https://doi.org/10.2174/1871530320666200729145100
Aydin A, Gayretli Yayla K. The assessment of Tp‐e interval and Tp‐e/QT ratio in patients with hyperthyroidism before and after thyroid surgery. International Journal of Clinical Practice. 2021;75(12):e14937. Available from: https://doi.org/10.1111/ijcp.14937
Aweimer A, Schiedat F, Schöne D, Landgrafe-Mende G, Bogossian H, Mügge A, et al. Abnormal cardiac repolarization in thyroid diseases: results of an observational study. Frontiers in Cardiovascular Medicine. 2021;8:738517. Available from: https://doi.org/10.3389/fcvm.2021.738517
Klein I, Danzi S. Thyroid disease and the heart. Current Problems in Cardiology. 2016;41(2):65–92. Available from: https://doi.org/10.1016/j.cpcardiol.2015.04.002
Sarma JSM, Venkataraman K, Nicod P, Polikar R, Smith J, Schoenbaum MP, et al. Circadian rhythmicity of rate-normalized QT interval in hypothyroidism and its significance for development of class III antiarrhythmic agents. The American Journal of Cardiology. 1990;66(12):959–963. Available from: https://doi.org/10.1016/0002-9149(90)90933-R
Binah O, Arieli R, Beck R, Rosen MR, Palti Y. Ventricular electrophysiological properties: is interspecies variability related to thyroid state? American Journal of Physiology-Heart and Circulatory Physiology. 1987;252(6):H1265–H1274. Available from: https://doi.org/10.1152/ajpheart.1987.252.6.H1265
Tayal B, Graff C, Selmer C, Kragholm KH, Kihlstrom M, Nielsen JB, et al. Thyroid dysfunction and electrocardiographic changes in subjects without arrhythmias: a cross-sectional study of primary healthcare subjects from Copenhagen. BMJ Open. 2019;9(6):e023854. Available from: https://doi.org/10.1136/bmjopen-2018-023854
Findikli HA, Tutak AŞ, Aydin H. The relationship between the TSH values and the Tpeak – Tend interval duration in hypothyroid patients receiving Levothyroxine treatment. Romanian Journal of Internal Medicine. 2019;57(2):175–180. Available from: https://doi.org/10.2478/rjim-2018-0042
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.